Paclitaxel-Fe(3)O(4) nanoparticles inhibit growth of CD138(−) CD34(−) tumor stem-like cells in multiple myeloma-bearing mice

BACKGROUND: There is growing evidence that CD138(−) CD34(−) cells may actually be tumor stem cells responsible for initiation and relapse of multiple myeloma. However, effective drugs targeted at CD138(−) CD34(−) tumor stem cells are yet to be developed. The purpose of this study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Cuiping, Wang, Jing, Chen, Dengyu, Chen, Junsong, Xiong, Fei, Zhang, Hongyi, Zhang, Yunxia, Gu, Ning, Dou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629869/
https://www.ncbi.nlm.nih.gov/pubmed/23610522
http://dx.doi.org/10.2147/IJN.S38447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629869/
https://www.ncbi.nlm.nih.gov/pubmed/23610522
http://dx.doi.org/10.2147/IJN.S38447

Ejemplares similares